Joseph J Eron Jr. MD

Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine

101 Manning DrChapel Hill, NC 27514
Phone+1 919-966-4996
Fax+1 919-843-5515

Dr. Eron is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Eron's full profile Already have an account?

Education & Training

Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1989 - 1992
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1987
Harvard Medical SchoolClass of 1984

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NC State Medical License 1992 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients
COMPLETED
PHASE1
Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV
COMPLETED
PHASE2
Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults
COMPLETED
NA

Publications & Presentations

PubMed

Lung cancer screening among people with HIV, 2018-2023.
Subhashini A Sellers, Lindsay E Browne, Heather I Henderson, Amanda E Moy, Deana M Agil
International Journal of STD & AIDS. 2026-09-01
Changes in HIV Clinical Visit Frequency and Viral Suppression During and After COVID-19 Restrictions: A Nested Study Within NA-ACCORD in the US, 2018-2021.
Yue Zhang, Brenna C Hogan, Kelly A Gebo, Peter F Rebeiro, Milton L Wainberg
Open Forum Infectious Diseases. 2026-09-01
Breaking the Chain: HIV-1 Transmission Clusters among People who Inject Drugs in North Carolina, 2010 to 2023.
Theppharit Panichsillapakit, Cara J Broshkevitch, Kimberly Enders, Annalea Greifinger, Shuntai Zhou
Journal of Acquired Immune Deficiency Syndromes. 2026-08-21

Journal Articles

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
Michael S Saag, Melanie A Thompson, Constance A Benson, Susan P Buchbinder, Joseph J Eron, Donna M Jacobsen, JAMA
Safety, Tolerability, and Pharmacokinetics of Long-Acting Injectable Cabotegravir in Low-Risk HIV-Uninfected Individuals: HPTN 077, a Phase 2a Randomized Controlled Trial
Susan H Eshleman, Joseph J Eron, Raphael J Landovitz, Myron S Cohen, Jeremy Sugarman, Mark A Marzinke, Craig W Hendrix, PLoS One
HIV Viral Suppression Trends over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study
Kenneth H Mayer, W Christopher Mathews, Michael J Mugavero, Richard D Moore, Joseph J Eron, Michael S Saag, Mari M Kitahata, Ira B Wilson, Heidi M Crane, Annals of Internal Medicine

Lectures

2013 Interscience Conference On Antimicrobial Agents & Chemotherapy
American Society For Microbology, Denver, Colorado - 9/10/2013

Press Mentions

Tpoxx Doesn’t Improve on Placebo in Achieving Key Mpox Outcomes, Phase 3 Trial ConcludesFebruary 26th, 2026
ACTG Presents SLIM LIVER Findings at AASLD Liver Meeting Demonstrating Improvements in Biomarkers of Cardiovascular Risk Among People Living with HIV and MASLD Who Receive SemaglutideNovember 10th, 2025
Gilead Presents Positive Proof-of-Concept Data for Investigational Combination Regimen of Lenacapavir with Broadly Neutralizing Antibodies as a Potential Twice-Yearly Approach for the Treatment of HIVFebruary 22nd, 2023

Grant Support

Leadership and Operations Center (LOC), AIDS Clinical Trials GroupUNIV OF NORTH CAROLINA CHAPEL HILL2025–2027
Leadership and Operations Center (LOC), AIDS Clinical Trials GroupUNIV OF NORTH CAROLINA CHAPEL HILL2025–2027
Leadership and Operations Center (LOC), AIDS Clinical Trials GroupUNIV OF NORTH CAROLINA CHAPEL HILL2025–2027
Leadership and Operations Center (LOC), AIDS Clinical Trials GroupUNIV OF NORTH CAROLINA CHAPEL HILL2025–2027
University of North Carolina Global HIV Prevention and Treatment Clinical Trials UnitUNIV OF NORTH CAROLINA CHAPEL HILL2007–2027

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Similar Physicians & HCPs

Nikolaos Mavrogiorgos, MD
IDChapel Hill, NC
Cynthia Gay, MD
IDChapel Hill, NC
David Wohl, MD
IDChapel Hill, NC
Becky White, MD
IDChapel Hill, NC
Arlene (Sena) Sena Soberano, MD
IDChapel Hill, NC
Michelle Floris-Moore, MD
IDChapel Hill, NC
David Weber, MD
IDChapel Hill, NC
Myron Cohen, MD
IDChapel Hill, NC
Mina Hosseinipour, MD
IDChapel Hill, NC
David Margolis, MD
IDChapel Hill, NC

Doximity / States / North Carolina / Chapel Hill / Joseph Eron Jr., MD

Dr. Joseph Eron, Dr. Joseph Eron, MD, Dr. J Eron, Dr. Joseph J Eron